eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

vol. 43
Clinical immunology

The level of myeloid-derived suppressor cells positively correlates with regulatory T cells in the blood of children with transient hypogammaglobulinaemia of infancy

Izabela Siemińska, Magdalena Rutkowska-Zapała, Karolina Bukowska-Strakova, Anna Gruca, Anna Szaflarska, Krzysztof Kobylarz, Maciej Siedlar, Jarek Baran

(Centr Eur J Immunol 2018; 43 (4): 413-420)
Online publish date: 2018/12/31
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Transient hypogammaglobulinaemia of infancy (THI) is a primary immunodeficiency characterised by low levels of immunoglobulin G (often with concomitant decrease of IgA and sometimes also of IgM) with still unknown exact reason. A delayed normalisation of the immunoglobulin level in THI may be associated with a transiently elevated number of regulatory T cells (Treg). Although in cancer and chronic inflammation it was shown that the level of Treg cells can be increased by myeloid-derived suppressor cells (MDSCs), until now no studies have been performed in the context of the role of MDSCs in THI and their correlation with Treg cells. Consequently, we aimed to determine the occurrence of MDSCs in the peripheral blood of children with THI and correlate their level with the level of Treg cells.

Material and methods
Flow cytometry analyses of Mo-MDSCs and Gr-MDSCs, characterised as HLA-DRCD11b+CD15CD14+ and HLA-DRCD11b+CD15+CD14, respectively, and Treg (CD4+CD25+Foxp3+) cells were performed.

The proportion of Mo-MDSCs and Gr-MDSCs was significantly higher in the group of THI patients with elevated level of Treg cells (from the 95% confidence interval level of healthy controls). The cells with Mo-MDSC and Gr-MDSC characteristics positively correlated with the level of Treg cells. Moreover, children with a higher proportion of circulating Treg cells, and thereby higher level of MDSCs, showed delayed normalisation of IgG level and recovery.

These findings show for the first time that MDSCs may be involved in the pathomechanism of THI, probably acting through the induction of Treg cells.


MDSCs, regulatory T cells, THI

Gabrilovich DI, Nagaraj S (2009): Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
Zamarron BF, Chen W (2011): Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7: 651-658.
Marvel D, Gabrilovich DI (2015): Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest 125: 3356-3364.
Bronte V, Brandau S, Chen S, et al. (2016): Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7: 1-10.
Dumitru CA, Lang S, Brandau S (2013): Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol 23: 141-148.
Brandau S, Trellakis S, Bruderek K, et al. (2011): Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 89: 311-317.
Pan PY, Li Q, Sato AI, et al. (2006): Gr-1+ CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host. Cancer Res 66: 1123-1131.
Fujimura T, Kambayashi Y, Aiba S (2012): Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth. Oncoimmunology 1: 1433-1434.
Pan PY, Ma Y, Weber KJ, et al. (2010): Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer. Cancer Res 70: 99-108.
Zea AH, Rodriguez PC, Culotta KS, et al. (2004): L-Arginine modulates CD3 expression and T cell function in activated human T lymphocytes. Cell Immunol 323: 21-31.
Schmielau J, Finn OJ (2001): Activated Granulocytes and Granulocyte-derived Hydrogen Peroxide Are the Underlying Mechanism of Suppression of T-Cell Function in Advanced Cancer Patients. Cancer Res 61: 4756-4760.
Youn JI, Gabrilovich DJ (2010): The biology of myeloid derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Imuunol 40: 2969-2975.
Haverkamp JM, Smith AM, Weinlich R, et al. (2014): Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. Immunity 41: 947-959.
Kumar V, Patel S, Tcyganov E, et al. (2016): The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37: 208-220.
Solito S, Marigo I, Pinton L, et al. (2014): Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci 1319: 47-65.
Brandau S, Moses K, Lang S (2013): Seminars in Cancer Biology The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer : Cousins, siblings or twins ?. Semin Cancer Biol 23: 171-182.
Ren JP, Zhao J, Dai J, et al. (2016): Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway. Immunology 148: 377-386.
Ost M, Singh A, Peschel A, et al. (2016): Myeloid-Derived Suppressor Cells in Bacterial Infections. Front Cell Infect Microbiol 6: 37.
Gońi O, Alcaide P, Fresno M (2002): Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+)CD11b(+) immature myeloid suppressor cells. Int Immunol 14: 1125-1134.
Makarenkova VP, Bansal V, Matta BM, et al. (2006): CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 176: 2085-2094.
Han C, Wu T, Na N, et al. (2016): The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice. Inflamm Res 65: 679-688.
Al-Muhsen S, Alsum Z (2012): Primary immunodeficiency diseases in the Middle East. Ann N Y Acad Sci 1250: 56-61.
Bernatowska E (2008): Pierwotne niedobory odporności. Pediatr Pol 83: 697-703.
Quinti I, Soresina A, Spadaro G, et al. 2007: Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency. J Clin Immunol 27: 308-316.
Conley ME, Notarangelo LD, Etzioni A (1999): Diagnostic Criteria for Primary Immunodeficiencies. Clin Immunol 93: 190-197.
Ovadia A, Dalal I (2014): Transient hypogammaglobulinemia of infancy. Lymph Sign J 1: 1-9.
Van Winkle RC, Hauck WW, McGeady SJ (2013): Phenotypic Parameters Predict Time to Normalization in Infants with Hypogammaglobulinemia. J Clin Immunol 33: 1336-1340.
Rutkowska M, Lenart M, Bukowska-Strakovà K, et al. (2011): The number of circulating CD4+ CD25highFoxp3+ T lymphocytes is transiently elevated in the early childhood of transient hypogammaglobulinemia of infancy patients. Clin Immunol 140: 307-310.
Rutkowska M, Trzyna E, Lenart M, et al. (2013): The elevated number of circulating regulatory T cells in patients with transient hypogammaglobulinemia of infancy is not associated with any abnormalities in the genes encoding the TGF- receptors. Clin Immunol 149: 83-85.
Dalal I, Roifman CM (2001): Hypogammaglobulinemia of infancy. Immunol Allergy Clin North Am 21: 129-139.
Conley ME, Notarangelo LD, Etzioni A (1999): Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: 190-197.
Lu T, Ramakrishnan R, Altiok S, et al. (2011): Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest 121: 4015-4029.
Sinha P, Clements VK, Bunt SK, et al. (2007): Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179: 977-983.
Serafini P, Mgebroff S, Noonan K, et al. (2008): Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells. Cancer Res 68: 5439-5449.
Lim HW, Hillsamer P, Banham AH, et al. (2005): Cutting edge: direct suppression of B - cells by CD4+ CD25+ regulatory T cells. J Immunol 175: 4180-4183.
Wang J, Yang L, Yu L, et al. (2017): Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer. Oncotarget 8: 17050.
Hoechst B, Ormandy LA, Ballmaier M, et al. (2008): A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+ CD25+ Foxp3+ T cells. Gastroenterology 135: 234-243.
Lee CR, Kwak Y, Yang T, et al. (2016): Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF- during murine colitis. Cell Reports 17: 3219-3232.
Lelis FJ, Jaufmann J, Singh A, et al. (2017): Myeloid-derived suppressor cells modulate B-cell responses. Immunol Lett 188: 108-115.
Meirow Y, Kanterman J, Baniyash M (2015): Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate. Front Immunol 6: 523.
Kowalczyk D, Mytar B, Zembala M (1997): Cytokine production in transient hypogammaglobulinemia and isolated IgA deficiency. J Allergy Clin Immunol 100: 556-562.
Kowalczyk D, Baran J, Webster ADB, et al. (2001): Intracellular cytokine – production by Th1/Th2 lymphocytes and monocytes of children with symptomatic transient hypogammaglobulinemia of infancy (THI) and selective IgA deficiency (SigAD). Clin Exp Immunol 127: 507-512.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe